Noked Israel’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-209,606
| Closed | -$3.22M | – | 16 |
|
|
2025
Q1 | $3.22M | Sell |
209,606
-3,075,753
| -94% | -$47.3M | 0.74% | 13 |
|
|
2024
Q4 | $72.4M | Buy |
3,285,359
+418,006
| +15% | +$9.21M | 14.25% | 3 |
|
|
2024
Q3 | $51.7M | Buy |
2,867,353
+1,182,353
| +70% | +$21.3M | 11.29% | 5 |
|
|
2024
Q2 | $27.4M | Buy |
+1,685,000
| New | +$27.4M | 7.56% | 6 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 31 |
|
|
2023
Q4 | – | Sell |
-962,000
| Closed | -$9.81M | – | 34 |
|
|
2023
Q3 | $9.81M | Buy |
+962,000
| New | +$9.81M | 2.98% | 12 |
|
|
2020
Q3 | – | Sell |
-2,956,700
| Closed | -$36.5M | – | 25 |
|
|
2020
Q2 | $36.5M | Buy |
2,956,700
+361,700
| +14% | +$4.46M | 26.07% | 1 |
|
|
2020
Q1 | $23.3M | Buy |
+2,595,000
| New | +$23.3M | 41.62% | 1 |
|
|
2019
Q2 | – | Sell |
-771,975
| Closed | -$12.1M | – | 99 |
|
|
2019
Q1 | $12.1M | Sell |
771,975
-667,300
| -46% | -$10.5M | 12.62% | 2 |
|
|
2018
Q4 | $22.2M | Buy |
+1,439,275
| New | +$22.2M | 18.59% | 1 |
|